Zevtera
Payments companies reported to CMS as associated with Zevtera. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zevtera, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zevtera
These are the largest totals companies reported as associated with Zevtera. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Samir Awad | Houston, TX | Surgical Critical Care | $19,564.59 |
| Javeed Siddiqui | Roseville, CA | Infectious Disease | $18,329.32 |
| Juan Diaz | Altamonte Springs, FL | Infectious Disease | $14,124.60 |
| Kamal Hamed | East Hanover, NJ | Infectious Disease | $12,100.00 |
| Michael Gelfand | Memphis, TN | Infectious Disease | $11,362.60 |
| Arthur Jeng | Sylmar, CA | Infectious Disease | $10,616.95 |
| George Sakoulas | San Diego, CA | Infectious Disease | $9,729.91 |
| Fares Khater | Whitesburg, KY | Internal Medicine | $8,725.10 |
| Miguel Sierra-Hoffman | Victoria, TX | Infectious Disease | $7,260.75 |
| Martin Gnoni | Louisville, KY | Infectious Disease | $6,335.78 |
Prescribed Zevtera?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.